Skip to main content
Premium Trial:

Request an Annual Quote

Not So Secret

Just how private is your DNA, asks an article in Salon. The story covers the pros and cons of inadvertently making your DNA public by buying personal genome services, for instance, and how your code might eventually be misused. "The promise of these tests includes drugs that may someday be tailored to treat your illnesses," the story says. "The peril is that your personal data could circulate more widely than you expect." Blaine Bettinger, who is a customer of 23andMe, was interviewed, and he's a bit more optimistic about data handling. "They have every incentive to keep information private," he says. "A security breach would be devastating for those companies."

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.